$STOK Stoke Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Stoke Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Stoke Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Stoke Therapeutics, Inc. for free.
IRS Number: 471144582
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: STOK
Company Address: 3 PRESTON COURT BEDFORD 01730
Phone number: (781) 430-8200
Former name: ASOthera Pharmaceuticals, Inc., date of change: 2014-10-28
Stoke Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | A | 60.00 | 200,800 | 12,048,000 | 200,800 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.60 | 7,882 | 4,729 | 8,764 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.40 | 1,842 | 737 | 0 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | M | 0.40 | 2,776 | 1,110 | 0 | |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Sell | S | 61.14 | 4,957 | 303,087 | 0 | 5 K to 0 (-100.00 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Sell | S | 60.55 | 7,543 | 456,754 | 4,957 | 12.5 K to 5 K (-60.34 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.60 | 7,882 | 4,729 | 12,500 | 4.6 K to 12.5 K (+170.68 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.40 | 1,842 | 737 | 4,618 | 2.8 K to 4.6 K (+66.35 %) |
| Mar 03 2021 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Buy | M | 0.40 | 2,776 | 1,110 | 2,776 | 0 to 2.8 K |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 5,000 | 22,400 | 179,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 25,000 | 112,000 | 184,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.60 | 5,000 | 292,992 | 602 | 5.6 K to 602 (-89.25 %) |